FBP1 and renal cell carcinoma: Dongen Ju et al. found that miR-24-1 inhibited the Warburg effect in cancer cells by targeting the active enhancer in the nucleus to activate FBP1 transcription and slow down aerobic glycolysis, ultimately preventing the development of renal cell carcinoma [30].